Event Date/Time: Nov 28, 2005
End Date/Time: Nov 29, 2005
The pharmaceutical industry is struggling to get small molecule targeted anticancer therapies successfully through clinical trials. This event will look at how clinical trial design and drug development needs to be adapted for targeted therapies, in particular taking into account the combination with cytotoxics. The latest case studies and regulatory insight will be presented, which will help those in oncology development, clinical research and development and clinical trial design to push their targeted agents through the pipeline to the market.